Protective effects of doxycycline in ischemia/reperfusion injury on kidney

Journal of Physiology and Biochemistry

Volumn 65, Issue 2, 2009, Pages 183-191

  Kucuk, A ^a   Kabadere, S ^b   Tosun, M ^c   Koken, T ^c   Kinaci, M K ^b   Isikli, B ^b   Erkasap, N ^b  

^a DUMLUPINAR UNIVERSITY   (Turkey)

^b ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^c AFYON KOCATEPE UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Doxycycline; Ischemia reperfusion; Kidney; Oxidative stress

Indexed keywords

DOXYCYCLINE; GELATINASE A; GLUTATHIONE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MALONALDEHYDE; PROTEIN P53; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; KIDNEY INJURY; KIDNEY ISCHEMIA; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; RENAL PROTECTION; REPERFUSION INJURY;

ANIMALS; APOPTOSIS; DOXYCYCLINE; GLUTATHIONE; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-2; INTERLEUKIN-6; KIDNEY; KIDNEY DISEASES; MALONDIALDEHYDE; MATRIX METALLOPROTEINASE 2; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; RATTUS;

EID: 70350065527     PISSN: 11387548     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03179069     Document Type: Article

References (30)

1. Ankan, Y., Tosun, M., Saykol, V., et al. (2008): P53 expression and apoptosis in liver and spleen during CO2 pneumoperitoneum. Langenbecks Arch Surg, 393, 877-882.
2. Avian, D., Tamer, L., Ayaz, L., et al. (2006): Effects of trapidil on renal ischemia-reperfusion injury. J Pediatr Surg, 41, 1686-1693. (Pubitemid 44441383)
3. Bálint, É, Vousden, KH. (2001): Activation and activities of the p53 tumor suppressor protein. Br J Cancer, 85, 1813-1823. (Pubitemid 34775315)
4. Chander, V., Chopra, K. (2005): Renal protective effect of molsidomine and L-Arginine in ischemia-reperfusion induced injury in rats. J Surg Res, 128, 132-139. (Pubitemid 41188221)
5. Clark, WM., Lessov, N., Lauten, JD., et al. (1997): Doxycycline treatment reduces ischemic brain damage in transient middle cerebral artery occlusion in the rat. J Mol Neurosci, 9, 103-108. (Pubitemid 127499160)
6. Daemen, MA., Van De Ven, MW., Heineman, E., et al. (1999): Involvement of endogenous interleukin-10 and tumor necrosis factor-α in renal ischemia-reperfusion injury. Transplantation, 67, 792-800. (Pubitemid 29169122)
7. Erkasap, S., Erkasap, N., Koken, T., et al. (2004): Effect of leptin on renal ischemia-reperfusion damage in rats. J Physiol Biochem, 60, 79-84. (Pubitemid 39213899)
8. Golub, LM., Lee, HM., Ryan, ME., et al. (1998): Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res, 12, 12-26.
9. Griffin, MO., Jinno, M., Miles, LA., et al. (2005): Reduction of myocardial infarct size by doxycycline: a role for plasmin inhibition. Mol Cell Biochem, 270, 1-11. (Pubitemid 40425232)
10. Kacmaz, A., Polat, A., User, Y., et al. (2003): Octreotide: a new approach to the management of acute abdominal hypertension. Peptides, 24, 1381-1386. (Pubitemid 38045545)
11. Kienle, K., Rentsch, M., Müler, T., et al. (2005): Expression of BCL-2 in liver grafts after adenoviral transfer improves survival following prolonged ischemia and reperfusion in rat liver transplantation. Transplantation Proc, 37, 439-441. (Pubitemid 40459811)
12. Krakauer, T., Buckley, M. (2003): Doxycycline is anti-inflammatory and inhibits staphylococcal exotoxin-induced cytokines and chemokines. Antimicrob Agents Chemother, 47, 3630-3633. (Pubitemid 37345735)
13. Liu, P., Xu, B., Spokas, E., et al. (2000): Role of endogenous nitric oxide in TNF-α and IL-1β generation in hepatic ischemia-reperfusion. Shock, 13, 217-223.
14. Mannello, F., Gazzanelli, G. (2001): Tissue inhibitors of metalloproteinases and programmed cell death: conundrums, controversies and potential implications. Apoptosis, 6, 479-482. (Pubitemid 33078759)
15. Mattson, DL., Wu, F. (2000): Nitric oxide synthase activity and isoforms in rat renal vasculature. Hypertension, 35, 337-341.
16. Mejia-Vilet, JM., Ramirez, V., Cruz, C., et al. (2007): Renal ischemia/reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone. Am J Physiol Renal Physiol, 293, F78-86. (Pubitemid 47345006)
17. Ozben, T. (2007): Oxidative stres and apoptosis: Impact on cancer therapy. J Pharm Sci, 96, 2181-2196.
18. Pitcher, J., Bradway, D., Meldrum, KK., et al. (2004): Trasylol (aprotinin) decreases kidney interleukin 1-beta and IL-6 levels following renal ischemia and reperfusion injury. J Surg Res, 121, 275.
19. Roach, DM., Fitridge, RA., Laws, PE., et al. (2002): Up-regulation of MMP-2 and MMP-9 leads to degradation of type IV collagen during skeletal muscle reperfusion injury; protection by the MMP inhibitor, doxycycline. Eur J Vasc Endovasc Surg, 23, 260-269.
20. Roczniak, A., Levine, DZ., Burns, KD. (2000): Localization of protein inhibitor of neuronal nitric oxide synthase in rat kidney. Am J Physiol, 278, F702-F707. (Pubitemid 30351071)
21. Sener, G., Sehirli, O., Velioglu-Ogunc, A., et al. (2006): Montelukast protects against renal ischemia reperfusion injury in rats. Pharm Res, 54, 65-71. (Pubitemid 43850825)
22. Shen, J., O'Brien, D., Xu, Y. (2006): Matrix metalloproteinase-2 contributes to tumor necrosis factor alpha induced apoptosis in cultured rat cardiac myocytes. Biochem Biophys Res Commun, 347, 1011-1020. (Pubitemid 44137344)
23. Smith, JR., Gabler, WL. (1994): Doxycycline suppression of ischemia-reperfusion-induced hepatic injury. Inflammation, 18, 193-201. (Pubitemid 24187004)
24. Tuǧtepe, H., Sener, G., Biyikli, NK., et al. (2007): The protective effect of oxytocin on renal ischemia/reperfusion injury in rats. Regul Pept, 140, 101-108. (Pubitemid 46418907)
25. Vinas, JL., Sola, A., Genesca, M., et al. (2006): NO and NOS isoforms in the development of apoptosis in renal ischemia/reperfusion. Free Rad Biol Med, 40, 992-1003. (Pubitemid 43376009)
26. Visse, R., Nagase, H. (2003): Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res, 92, 827-839. (Pubitemid 36542523)
27. Volti, GL., Sorrenti, V., Murabito, P., et al. (2007): Pharmocological induction of heme oxygenase-1 inhibits iNOS and oxidative stress in renal ischemia-reperfusion injury. Transplant Proc, 39, 2986-2991. (Pubitemid 350251511)
28. Xiao, QG., Liu, ZG., Zhang, M., et al. (2005): Effect of doxycycline on inflammation-related cytokines and apoptosis in human conjunctival epithelial cells. Zhonghua Yan Ke Za Zhi, 41, 842-846.
29. Yang, XY., Jiang, SQ., Zhang, L., et al. (2007): Inhibitory effect of dauricine on inflammatory process following focal cerebral ischemia/reperfusion in rats. Am J Chin Med, 35, 477-486. (Pubitemid 47018593)
30. Yeh, YC., Lai, HC., Ting, CT., et al. (2007): Protection by doxycycline against doxorubicin-induced oxidative stress and apoptosis in mouse testes. Biochem Pharmacol, 74, 969-980.